IGC Pharma's total assets for Q1 2026 were $7.94M, a decrease of -9.19% from the previous quarter. IGC total liabilities were $1.86M for the fiscal quarter, a -22.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.